The University of Chicago Header Logo

Connection

Walter M. Stadler to HSP90 Heat-Shock Proteins

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about HSP90 Heat-Shock Proteins.
Walter M. Stadler
Connection Strength
0.095
HSP90 Heat-Shock Proteins
  1. Multicenter phase II trial of the heat shock protein 90 inhibitor, retaspimycin hydrochloride (IPI-504), in patients with castration-resistant prostate cancer. Urology. 2011 Sep; 78(3):626-30.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.